Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director · president and CEO | September 28, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 66,418 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Sale · Disposed 2,000 · Balance 66,418 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2023 Filed Nov 1, 2023 19:37 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,000 | $560.68 | $2,803,400.00 |
DisclosureSEC source: 0001209191-23-054007 · doc4.xml · nonDerivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,968 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.59 to $564.89. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| October 31, 2023 Filed Nov 1, 2023 19:37 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 13,647 | $562.32 | $7,673,981.04 |
DisclosureSEC source: 0001209191-23-054007 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,968 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| October 31, 2023 Filed Nov 1, 2023 19:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 10,000 | $445.35 | $4,453,500.00 |
DisclosureSEC source: 0001209191-23-054007 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2023 Filed Nov 1, 2023 19:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 5,700 | $413.19 | $2,355,183.00 |
DisclosureSEC source: 0001209191-23-054007 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2023 Filed Oct 26, 2023 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 37,756 | $509.46 Strike: $509.46 | $19,235,171.76 |
DisclosureSEC source: 0001209191-23-053621 · doc4.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,855 Underlying: capital stock · 37,756 shares Expires 2028-10-25 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/25/2024. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 3,000 | $413.19 Strike: $413.19 | $1,239,570.00 |
DisclosureSEC source: 0001209191-23-044726 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,099 Underlying: capital stock · 3,000 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 2,656 | $516.79 | $1,372,594.24 |
DisclosureSEC source: 0001209191-23-044726 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,915 F2 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 3,000 | $413.19 | $1,239,570.00 |
DisclosureSEC source: 0001209191-23-044726 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 4,000 | $516.43 | $2,065,720.00 |
DisclosureSEC source: 0001209191-23-044726 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,571 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.75 to $516.98. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 05, 2023 Filed May 8, 2023 17:02 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 4,000 | $549.34 | $2,197,360.00 |
DisclosureSEC source: 0001209191-23-027883 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,571 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.77 to $551.38. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 03, 2023 Filed May 3, 2023 18:34 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 31,500 | $413.19 Strike: $413.19 | $13,015,485.00 |
DisclosureSEC source: 0001209191-23-026906 · doc4.xml · derivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,099 Underlying: capital stock · 31,500 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| May 03, 2023 Filed May 3, 2023 18:34 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 27,040 | $549.27 | $14,852,260.80 |
DisclosureSEC source: 0001209191-23-026906 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,571 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 03, 2023 Filed May 3, 2023 18:34 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 31,500 | $413.19 | $13,015,485.00 |
DisclosureSEC source: 0001209191-23-026906 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2023 Filed May 2, 2023 15:52 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 3,500 | $413.19 Strike: $413.19 | $1,446,165.00 |
DisclosureSEC source: 0001209191-23-026416 · doc4.xml · derivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,599 Underlying: capital stock · 3,500 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| May 02, 2023 Filed May 2, 2023 15:52 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 3,002 | $550.48 | $1,652,540.96 |
DisclosureSEC source: 0001209191-23-026416 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,111 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 02, 2023 Filed May 2, 2023 15:52 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 3,500 | $413.19 | $1,446,165.00 |
DisclosureSEC source: 0001209191-23-026416 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $526.27 | $1,578,810.00 |
DisclosureSEC source: 0001209191-23-021464 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,613 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.92 to $527.54. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 16:31 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,000 | $507.32 | $1,014,640.00 |
DisclosureSEC source: 0001209191-23-017735 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,613 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.92 to $509.00. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 18:47 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 4,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011538 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,894 Underlying: capital stock · 4,374 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 18:47 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011538 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,520 Underlying: capital stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 18:47 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011538 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,859 Underlying: capital stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 18:47 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,896 | $515.12 | $976,667.52 |
DisclosureSEC source: 0001209191-23-011538 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,613 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 18:47 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 1,540 | $515.12 | $793,284.80 |
DisclosureSEC source: 0001209191-23-011538 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2020 through December 31, 2022, compared to a defined peer group of companies. The Company's performance ranked in the 55.6th percentile of that group, yielding an award of 113.89%; including the reinvestment of dividends paid during such period, the award is 115% of target. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 18:47 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 2,705 | $515.12 | $1,393,399.60 |
DisclosureSEC source: 0001209191-23-011538 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2020 through December 31, 2022. The actual performance of 12.67% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202% of target. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 15:59 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,000 | $505.76 | $1,011,520.00 |
DisclosureSEC source: 0001209191-22-058312 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,264 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.14 to $506.47. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 5,000 | $306.70 Strike: $306.70 | $1,533,500.00 |
DisclosureSEC source: 0001209191-22-055761 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,099 Underlying: capital stock · 5,000 shares Expires 2023-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 5,000 | $306.70 | $1,533,500.00 |
DisclosureSEC source: 0001209191-22-055761 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 3,971 | $479.27 | $1,903,181.17 |
DisclosureSEC source: 0001209191-22-055761 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,264 F2 · shares: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,000 | $482.90 | $965,800.00 |
DisclosureSEC source: 0001209191-22-055761 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,235 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $480.90 to $485.37. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 14:27 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 35,772 | $462.04 Strike: $462.04 | $16,528,094.88 |
DisclosureSEC source: 0001209191-22-055182 · doc4.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,099 Underlying: capital stock · 35,772 shares Expires 2027-10-31 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/31/2023 Read SEC document |
| September 13, 2022 Filed Sep 14, 2022 17:58 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,000 | $474.13 | $948,260.00 |
DisclosureSEC source: 0001209191-22-049860 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,235 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $473.69 to $474.87. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 22, 2022 Filed Aug 22, 2022 17:16 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 5,000 | $306.70 Strike: $306.70 | $1,533,500.00 |
DisclosureSEC source: 0001209191-22-046983 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,327 Underlying: capital stock · 5,000 shares Expires 2023-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
| August 22, 2022 Filed Aug 22, 2022 17:16 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 3,950 | $484.94 | $1,915,513.00 |
DisclosureSEC source: 0001209191-22-046983 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,235 F2 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 22, 2022 Filed Aug 22, 2022 17:16 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 5,000 | $306.70 | $1,533,500.00 |
DisclosureSEC source: 0001209191-22-046983 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 17:16 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $481.93 | $1,445,790.00 |
DisclosureSEC source: 0001209191-22-046983 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,185 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $480.63 to $484.49. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 10, 2022 Filed May 11, 2022 15:16 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,000 | $502.00 | $1,004,000.00 |
DisclosureSEC source: 0001209191-22-028215 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,185 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $499.02 to $504.61. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 02, 2022 Filed May 4, 2022 14:33 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 10,000 | $306.70 Strike: $306.70 | $3,067,000.00 |
DisclosureSEC source: 0001209191-22-026964 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,327 Underlying: capital stock · 10,000 shares Expires 2032-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
| May 02, 2022 Filed May 4, 2022 14:33 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 7,863 | $489.91 | $3,852,162.33 |
DisclosureSEC source: 0001209191-22-026964 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,185 F2 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 02, 2022 Filed May 4, 2022 14:33 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 10,000 | $306.70 | $3,067,000.00 |
DisclosureSEC source: 0001209191-22-026964 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2022 Filed May 4, 2022 14:33 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $486.79 | $1,460,370.00 |
DisclosureSEC source: 0001209191-22-026964 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,048 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $479.67 to $496.16. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 19:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 10,000 | $306.70 Strike: $306.70 | $3,067,000.00 |
DisclosureSEC source: 0001209191-22-017498 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,327 Underlying: capital stock · 10,000 shares Expires 2023-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 19:29 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $469.91 | $1,409,730.00 |
DisclosureSEC source: 0001209191-22-017498 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,048 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $466.32 to $473.66. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 19:29 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 7,973 | $475.22 | $3,788,929.06 |
DisclosureSEC source: 0001209191-22-017498 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,048 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 19:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 10,000 | $306.70 | $3,067,000.00 |
DisclosureSEC source: 0001209191-22-017498 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:25 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 4,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012049 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,198 Underlying: capital stock · 4,046 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012049 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,152 Underlying: capital stock · 2,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. F5 · derivative.expiration_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012049 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,616 Underlying: capital stock · 2,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. F5 · derivative.expiration_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:25 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 3,671 | $459.77 | $1,687,815.67 |
DisclosureSEC source: 0001209191-22-012049 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,021 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 3,243 | $459.77 | $1,491,034.11 |
DisclosureSEC source: 0001209191-22-012049 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2019 through December 31, 2021, compared to a defined peer group of companies. The Company's performance ranked in the 63rd percentile of that group, yielding an award of 130.26%; including the reinvestment of dividends paid during such period, the award is 131.6% of target. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 4,977 | $459.77 | $2,288,275.29 |
DisclosureSEC source: 0001209191-22-012049 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2019 through December 31, 2021. The actual performance of 18.63% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.